• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Frailty as a predictor of mortality on admission to intermediate care

byKeerthana PasumarthiandAlex Chan
September 6, 2022
in Chronic Disease, Public Health
Reading Time: 2 mins read
Frailty as a predictor of mortality on admission to intermediate care
Share on FacebookShare on TwitterShare on LinkedIn

1. Frailty status upon admission to intermediate care was a strong predictor of mortality. 

Evidence Rating Level: 2 (Good) 

Frailty can be defined as a significant reduction in function and health in older adults secondary to a dysregulation in multiple physiological systems. This can have negative implications for health outcomes such as mortality and hospitalization in geriatric populations. Transitions in level of frailty can be further propagated by hospitalization; however, these specific transitions have not been specifically discussed in literature. In this prospective observational study conducted in Spain, 483 participants admitted to intermediate care (IC) facilities were assessed for degree of frailty using a frailty index (Frail-VIG). Degree of frailty was assessed 30 days prior to admission, within 48 hours following admission, at discharge, and 30 days post discharge. The results show that compared to baseline, most patients worsen in frailty after admission. As well, a higher frailty status upon admission was associated with an increased risk of mortality (HR 1.16, 95%CI 1.10-1.22). In conclusion, frailty status changed after admission to intermediate care, and this was a significant predictor for mortality. Further research exploring various factors contributing to worsening frailty amongst hospitalized individuals could be very valuable. However, this study is limited in its methodology. As the focus of this study was on individuals admitted to intermediate care, these findings cannot be generalized to all hospitalized patients. Additionally, frailty is often affected by other factors including socioeconomic status, race, gender, and psychological wellbeing. The effect of these factors on the participants in study were not discussed in detail. Nevertheless, this study provides great insight into frailty and how it can be exacerbated by hospitalizations in elderly patients, ultimately causing poor health outcomes. 

Click to read the study in BMC Geriatrics

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Housing insecurity is associated with increased risk of geriatric conditions and mortality

2 Minute Medicine Rewind May 4, 2026

Tags: chronic diseasegeriatricsinternal medicine
Previous Post

Combination therapy more effective than monotherapy for diabetic peripheral neuropathic pain

Next Post

#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

RelatedReports

Frailty as a predictor of mortality on admission to intermediate care
Chronic Disease

Housing insecurity is associated with increased risk of geriatric conditions and mortality

May 7, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Chronic Disease

A multidisciplinary home-based intervention may reduce risk of falls after stroke

April 3, 2026
Unpaid caregivers of older adults experience emotional, physical, and financial difficulty
Imaging and Intervention

A telephone-based intervention reduced loneliness and improved well-being among older adults

February 12, 2026
Next Post
#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

“No Evidence of Disease Activity” may be useful goal in multiple sclerosis

Excitatory noninvasive brain stimulation interventions improved negative symptoms in schizophrenia

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

CT not sufficient to rule out early subarachnoid hemorrhage [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pennsylvania reports 1,260 measles cases across 43 counties in 2026
  • Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma
  • Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.